| # | Drug | Count |
|---|---|---|
| 0 | IMATINIB | 16 |
| 1 | DASATINIB | 15 |
| 2 | RITUXIMAB | 13 |
| 3 | CYTARABINE | 12 |
| 4 | PREDNISONE | 10 |
| 5 | CYCLOPHOSPHAMIDE | 9 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 9 |
| 8 | ACETAMINOPHEN | 8 |
| 9 | METHOTREXATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOY ISOFLAVONES | 1 | 0.0128 |
| 1 | SODIUM PHENYLBUTYRATE | 1 | 0.0024 |
| 2 | DASATINIB | 15 | 0.0016 |
| 3 | LEVOLEUCOVORIN INJECTION | 3 | 0.0010 |
| 4 | LEVOLEUCOVORIN | 3 | 0.0008 |
| 5 | PLERIXAFOR | 1 | 0.0007 |
| 6 | SARGRAMOSTIM | 1 | 0.0006 |
| 7 | THIOGUANINE | 1 | 0.0005 |
| 8 | VORINOSTAT | 1 | 0.0005 |
| 9 | TELMISARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 22 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 2 | Alkylating Drug [EPC] | 15 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 15 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 5 | Kinase Inhibitor [EPC] | 9 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 8 |
| 7 | Platinum-based Drug [EPC] | 8 |
| 8 | Proton Pump Inhibitor [EPC] | 7 |
| 9 | Benzodiazepine [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 1 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 2 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 5 | Nitrofuran Antibacterial [EPC] | 4 | 0.0002 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Bismuth [EPC] | 1 | 0.0002 |
| 8 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 9 | Recombinant Human Growth Hormone [EPC] | 3 | 0.0001 |